# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched the IP Collaboration Hub™ ...
Clarivate announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap...
Clarivate Plc launched AI-enhanced Trademark Watch Analyzer at 2024 International Trademark Association Annual Meeting, connect...
Providing faster and more accurate answers to critical business questions LONDON, May 20, 2024 /PRNewswire/ -- Clarivate Plc (...
Goldman Sachs analyst George Tong maintains Clarivate (NYSE:CLVT) with a Buy and lowers the price target from $8.5 to $7.5.
Clarivate (NYSE:CLVT) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 22.22 ...
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for p...